Massimo Zucchetti

9PUBLICATIONS
61CO-AUTHORS
NeonatologyPredictive and prognostic markersHaematological tumoursInfant and child healthCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Dec 14, 2023
Four Additional Doses of PEG-L-Asparaginase During the Consolidation Phase in the AIEOP-BFM ALL 2009 Protocol Do Not Improve Outcome and Increase Toxicity in High-Risk ALL: Results of a Randomized Study.

Valentino Conter, Maria Grazia Valsecchi, Gunnar Cario

|May 13, 2022
Pharmacological and clinical monitoring in children with acute lymphoblastic leukemia treated with a biogeneric PEG-l-asparaginase product.

Cristina Matteo, Antonella Colombini, Laura Rachele Bettini

|Feb 17, 2021
Population Pharmacokinetics of PEGylated Asparaginase in Children with Acute Lymphoblastic Leukemia: Treatment Phase Dependency and Predictivity in Case of Missing Data.

Gudrun Würthwein, Claudia Lanvers-Kaminsky, Christian Siebel

|Feb 28, 2020
High-dose vitamin C enhances cancer immunotherapy.

Alessandro Magrì, Giovanni Germano, Annalisa Lorenzato

Pageof 2